IN2012DN05888A - - Google Patents
Info
- Publication number
- IN2012DN05888A IN2012DN05888A IN5888DEN2012A IN2012DN05888A IN 2012DN05888 A IN2012DN05888 A IN 2012DN05888A IN 5888DEN2012 A IN5888DEN2012 A IN 5888DEN2012A IN 2012DN05888 A IN2012DN05888 A IN 2012DN05888A
- Authority
- IN
- India
- Prior art keywords
- pro
- emulsion formulations
- taxane
- kits
- making
- Prior art date
Links
- 239000000839 emulsion Substances 0.000 abstract 4
- 238000009472 formulation Methods 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 229940123237 Taxane Drugs 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30631510P | 2010-02-19 | 2010-02-19 | |
| PCT/US2011/025418 WO2011103413A2 (en) | 2010-02-19 | 2011-02-18 | Taxane pro-emulsion formulations and methods making and using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN05888A true IN2012DN05888A (enExample) | 2015-09-18 |
Family
ID=44477026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN5888DEN2012 IN2012DN05888A (enExample) | 2010-02-19 | 2011-02-18 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8569357B2 (enExample) |
| EP (1) | EP2536407A4 (enExample) |
| JP (1) | JP2013520435A (enExample) |
| KR (1) | KR20120126072A (enExample) |
| CN (1) | CN102762202A (enExample) |
| AU (1) | AU2011217951B2 (enExample) |
| IN (1) | IN2012DN05888A (enExample) |
| TW (1) | TWI438009B (enExample) |
| WO (1) | WO2011103413A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104394885B (zh) * | 2012-05-31 | 2017-06-30 | 学校法人近畿大学 | 抗癌剂所致的末梢神经障碍性疼痛的预防和/或治疗剂 |
| JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
| US11497795B2 (en) | 2018-09-28 | 2022-11-15 | Asahi Kasei Pharma Corporation | Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5580575A (en) | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
| US5407683A (en) | 1990-06-01 | 1995-04-18 | Research Corporation Technologies, Inc. | Pharmaceutical solutions and emulsions containing taxol |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| FR2678833B1 (fr) | 1991-07-08 | 1995-04-07 | Rhone Poulenc Rorer Sa | Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes. |
| US5698582A (en) | 1991-07-08 | 1997-12-16 | Rhone-Poulenc Rorer S.A. | Compositions containing taxane derivatives |
| US5750561A (en) | 1991-07-08 | 1998-05-12 | Rhone-Poulenc Rorer, S.A. | Compositions containing taxane derivatives |
| DE4208527A1 (de) | 1992-03-17 | 1993-09-23 | Max Planck Gesellschaft | Liposomen mit negativer ueberschussladung |
| US5602112A (en) | 1992-06-19 | 1997-02-11 | Supergen, Inc. | Pharmaceutical formulation |
| DK0674510T3 (da) | 1992-11-27 | 1999-05-10 | Napro Biotherapeutics Inc | Injicerbart præparat omfattende paclitaxel |
| FR2698543B1 (fr) | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouvelles compositions à base de taxoides. |
| US5439686A (en) | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
| US6749868B1 (en) | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| WO1994018954A1 (en) | 1993-02-22 | 1994-09-01 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of biologics and compositions useful therefor |
| US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
| US6753006B1 (en) | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
| US6096331A (en) | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
| US5885486A (en) | 1993-03-05 | 1999-03-23 | Pharmaciaand Upjohn Ab | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof |
| US5785976A (en) | 1993-03-05 | 1998-07-28 | Pharmacia & Upjohn Ab | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof |
| US5415869A (en) | 1993-11-12 | 1995-05-16 | The Research Foundation Of State University Of New York | Taxol formulation |
| US5925669A (en) | 1994-03-22 | 1999-07-20 | Molecular/Structural Bio Technologies, Inc. | Carrier compositions for anti-neoplastic drugs |
| US5616330A (en) | 1994-07-19 | 1997-04-01 | Hemagen/Pfc | Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
| DE4430593C2 (de) | 1994-08-20 | 1999-01-14 | Max Delbrueck Centrum | Verfahren zur Herstellung von Liposomal verkapseltem Taxol |
| DE4440337A1 (de) | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
| US5789000A (en) | 1994-11-14 | 1998-08-04 | Bionumerik Pharmaceuticals, Inc. | Sterile aqueous parenteral formulations of cis-diammine dichloro platinum |
| US5580899A (en) | 1995-01-09 | 1996-12-03 | The Liposome Company, Inc. | Hydrophobic taxane derivatives |
| US5716928A (en) | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| EP0760237A1 (en) | 1995-08-30 | 1997-03-05 | Cipla Limited | Oil-in-water microemulsions |
| KR100330373B1 (ko) | 1996-05-28 | 2002-11-07 | 주식회사한국신약 | 탁솔을 함유한 주사용 약제 조성물 |
| US5877205A (en) | 1996-06-28 | 1999-03-02 | Board Of Regents, The University Of Texas System | Parenteral paclitaxel in a stable non-toxic formulation |
| US6458373B1 (en) * | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| US6727280B2 (en) | 1997-01-07 | 2004-04-27 | Sonus Pharmaceuticals, Inc. | Method for treating colorectal carcinoma using a taxane/tocopherol formulation |
| US6121245A (en) | 1997-01-29 | 2000-09-19 | Firshein; Richard N. | Method of treating cancer using alkylglycerols in conjunction with chemotherapy |
| PL192080B1 (pl) | 1997-07-29 | 2006-08-31 | Upjohn Co | Kompozycja farmaceutyczna zawierająca związek piranonowy |
| US6090407A (en) | 1997-09-23 | 2000-07-18 | Research Development Foundation | Small particle liposome aerosols for delivery of anti-cancer drugs |
| US6281175B1 (en) | 1997-09-23 | 2001-08-28 | Scimed Life Systems, Inc. | Medical emulsion for lubrication and delivery of drugs |
| AU2845599A (en) | 1998-03-05 | 1999-09-20 | Phares Pharmaceutical Research N.V. | Pharmaceutical compositions and their use |
| US6979456B1 (en) | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
| AR019308A1 (es) | 1998-05-20 | 2002-02-13 | Liposome Co Inc | Formulaciones de particulas novedosas. |
| US7030155B2 (en) | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| US6071952A (en) | 1998-12-02 | 2000-06-06 | Mylan Pharmaceuticals, Inc. | Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| US6761903B2 (en) | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| US6537585B1 (en) | 1999-03-26 | 2003-03-25 | Guilford Pharmaceuticals, Inc. | Methods and compositions for treating solid tumors |
| EP1185301A1 (en) * | 1999-05-24 | 2002-03-13 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| US6610317B2 (en) * | 1999-05-27 | 2003-08-26 | Acusphere, Inc. | Porous paclitaxel matrices and methods of manufacture thereof |
| US6395300B1 (en) | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| CN100376291C (zh) * | 1999-05-27 | 2008-03-26 | 阿库斯菲尔公司 | 多孔药物基质及其制造方法 |
| TW422706B (en) | 1999-07-01 | 2001-02-21 | Wang Iz Rung | An oil-in-water emulsion type of paclitaxel |
| WO2001025223A1 (en) | 1999-10-06 | 2001-04-12 | The Research Foundation Of State University Of New York | Stabilization of taxane-containing dispersed systems |
| US6720001B2 (en) | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| CA2367661A1 (en) | 2000-02-02 | 2001-08-09 | Robert A. Holton | Taxane formulations having improved solubility |
| JP3448006B2 (ja) | 2000-03-29 | 2003-09-16 | 独立行政法人食品総合研究所 | 機能性エマルション |
| US6761901B1 (en) | 2000-05-02 | 2004-07-13 | Enzrel Inc. | Liposome drug delivery |
| DE10036871A1 (de) | 2000-07-28 | 2002-02-14 | Pharmasol Gmbh | Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe |
| US20030099674A1 (en) * | 2001-08-11 | 2003-05-29 | Chen Andrew X. | Lyophilized injectable formulations containing paclitaxel or other taxoid drugs |
| US20060078618A1 (en) * | 2001-12-11 | 2006-04-13 | Constantinides Panayiotis P | Lipid particles and suspensions and uses thereof |
| ATE345277T1 (de) | 2002-08-21 | 2006-12-15 | Pharmacia Corp | Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern |
| US7345093B2 (en) | 2004-04-27 | 2008-03-18 | Formatech, Inc. | Methods of enhancing solubility of compounds |
| US8557861B2 (en) | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| AR054215A1 (es) | 2006-01-20 | 2007-06-13 | Eriochem Sa | Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit |
| WO2008105852A2 (en) * | 2006-10-26 | 2008-09-04 | Creighton University | Mucoadhesive nanoparticles for cancer treatment |
| EA201100069A1 (ru) * | 2008-07-23 | 2011-10-31 | Бхарат Сирумс Энд Вэксинс Лтд. | Стабильная инъецируемая наноэмульсия доцетакселя |
| CN101428002A (zh) * | 2008-11-20 | 2009-05-13 | 沈阳万爱普利德医药科技有限公司 | 注射用紫杉醇冻干微乳剂及其制备方法 |
-
2011
- 2011-02-17 TW TW100105178A patent/TWI438009B/zh not_active IP Right Cessation
- 2011-02-18 AU AU2011217951A patent/AU2011217951B2/en not_active Ceased
- 2011-02-18 IN IN5888DEN2012 patent/IN2012DN05888A/en unknown
- 2011-02-18 WO PCT/US2011/025418 patent/WO2011103413A2/en not_active Ceased
- 2011-02-18 EP EP11745314.2A patent/EP2536407A4/en not_active Withdrawn
- 2011-02-18 CN CN2011800094323A patent/CN102762202A/zh active Pending
- 2011-02-18 US US13/030,495 patent/US8569357B2/en active Active
- 2011-02-18 JP JP2012554053A patent/JP2013520435A/ja active Pending
- 2011-02-18 KR KR1020127018554A patent/KR20120126072A/ko not_active Ceased
-
2013
- 2013-09-12 US US14/025,695 patent/US20140088181A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011103413A3 (en) | 2012-01-12 |
| WO2011103413A2 (en) | 2011-08-25 |
| US8569357B2 (en) | 2013-10-29 |
| EP2536407A4 (en) | 2013-08-14 |
| AU2011217951A1 (en) | 2012-07-19 |
| US20140088181A1 (en) | 2014-03-27 |
| EP2536407A2 (en) | 2012-12-26 |
| CN102762202A (zh) | 2012-10-31 |
| JP2013520435A (ja) | 2013-06-06 |
| KR20120126072A (ko) | 2012-11-20 |
| AU2011217951B2 (en) | 2013-07-11 |
| US20110207803A1 (en) | 2011-08-25 |
| TW201141538A (en) | 2011-12-01 |
| TWI438009B (zh) | 2014-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2012077120A3 (en) | Natural formulations | |
| WO2012051210A3 (en) | Mesenchymal stem cells and related therapies | |
| WO2013123114A3 (en) | Anti-vla1 (cd49a) antibody pharmaceutical compositions | |
| GEP201706733B (en) | Anti-il-23 antibodies | |
| WO2012099930A3 (en) | Flavonol compositions | |
| MY170720A (en) | Antibody formulations | |
| ZA201401782B (en) | Chromobacterium formulations,compositions,metabolites and their uses | |
| AU2013225816A8 (en) | Compositions and methods for treating Type III Gaucher Disease | |
| EP3074000A4 (en) | Suspension compositions of physiologically active phenolic compounds&methods of making and using the same | |
| EP3068500A4 (en) | Fertilizer compositions and methods of making and using the same | |
| MY167224A (en) | Non-Aqueous Taxane Pro-Emulsion Formulations and Methods of Making and Using the Same | |
| IN2012DN03404A (enExample) | ||
| WO2012075117A3 (en) | Small molecule-polymer conjugates and methods of making same | |
| WO2013123046A3 (en) | Cathode buffer materials and related devices and methods | |
| CA2875305C (en) | Fbxo3 inhibitors | |
| WO2012088222A3 (en) | Methods and compositions for producing active vitamin k-dependent proteins | |
| WO2011050188A8 (en) | Anti-hepsin antibodies and methods using same | |
| EP2640953A4 (en) | Propellant compositions and methods of making and using the same | |
| IN2012DN05888A (enExample) | ||
| MX2013000539A (es) | Nuevas formulaciones de analogos 14-epi de la vitamina d. | |
| WO2012051126A3 (en) | Anti-inflammatory macrolides | |
| WO2014003950A3 (en) | Selenium containing nucleosides as nutritional supplements | |
| WO2012139074A3 (en) | Migrastatins and uses thereof | |
| WO2012004073A3 (de) | Verwendung von beta-isophoron als lösemittel | |
| PH12012501547A1 (en) | Methods of preparing thiazolidines |